Presence of 1q21 gain and amplification may be associated with poorer outcomes in Daratumumab-treated Multiple Myeloma Patients
Authors
Kenneth Lim,
Cameron WellardElizabeth Moore,
Slavisa Ninkovic,
Wee Chng,
Andrew Spencer,
Peter Mollee,
Jay Hocking,
P. Ho,
Wojt Janowski,
Kihyun Kım,
Georgia McCaughan,
Karen Dun,
Zoe McQuilten,
Fiona Chen +13 authors
,
Hang Quach Tip Tip